Recursion Pharmaceuticals, Inc. (RXRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ABSI, AFMD, AVRO, CNSP, CWBR and others.
RXRX has a market capitalization of $1.58B, compared to an average peer market cap of $285.31M. RXRX is significantly larger than its average peer.